Immunosuppressive therapy for autoimmune inner ear disease

Maria C. Buniel, Katie Geelan-Hansen, Peter C. Weber, Vincent K. Tuohy

Research output: Contribution to journalReview article

28 Citations (Scopus)

Abstract

Autoimmune inner ear disease (AIED) is a rare disease that is diagnosed after clinical suspicion and response to corticosteroids. AIED manifests as progressive, bilateral, although often asynchronous, sensorineural hearing loss and can be associated with vestibular symptoms. Since its description as a defined disease entity in 1979, the initial mainstay of treatment remains high-dose corticosteroids. Several animal models have been developed to assist in determining efficacy of immunosuppression in AIED, and several clinical studies have also investigated the role of both steroid and steroid-sparing treatments. Here we discuss the basic science and clinical research surrounding the history of immunosuppressive therapy in AIED.

Original languageEnglish (US)
Pages (from-to)425-434
Number of pages10
JournalImmunotherapy
Volume1
Issue number3
DOIs
StatePublished - Dec 24 2009

Fingerprint

Labyrinth Diseases
Immunosuppressive Agents
Adrenal Cortex Hormones
Steroids
Sensorineural Hearing Loss
Therapeutics
Rare Diseases
Immunosuppression
Animal Models
History
Research

Keywords

  • Autoimmunity
  • Corticosteroid
  • Hearing loss
  • Immunomodulation
  • Immunosuppression

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology

Cite this

Immunosuppressive therapy for autoimmune inner ear disease. / Buniel, Maria C.; Geelan-Hansen, Katie; Weber, Peter C.; Tuohy, Vincent K.

In: Immunotherapy, Vol. 1, No. 3, 24.12.2009, p. 425-434.

Research output: Contribution to journalReview article

Buniel, Maria C. ; Geelan-Hansen, Katie ; Weber, Peter C. ; Tuohy, Vincent K. / Immunosuppressive therapy for autoimmune inner ear disease. In: Immunotherapy. 2009 ; Vol. 1, No. 3. pp. 425-434.
@article{b492bb5e875845cb961a9b1d2d0bc74f,
title = "Immunosuppressive therapy for autoimmune inner ear disease",
abstract = "Autoimmune inner ear disease (AIED) is a rare disease that is diagnosed after clinical suspicion and response to corticosteroids. AIED manifests as progressive, bilateral, although often asynchronous, sensorineural hearing loss and can be associated with vestibular symptoms. Since its description as a defined disease entity in 1979, the initial mainstay of treatment remains high-dose corticosteroids. Several animal models have been developed to assist in determining efficacy of immunosuppression in AIED, and several clinical studies have also investigated the role of both steroid and steroid-sparing treatments. Here we discuss the basic science and clinical research surrounding the history of immunosuppressive therapy in AIED.",
keywords = "Autoimmunity, Corticosteroid, Hearing loss, Immunomodulation, Immunosuppression",
author = "Buniel, {Maria C.} and Katie Geelan-Hansen and Weber, {Peter C.} and Tuohy, {Vincent K.}",
year = "2009",
month = "12",
day = "24",
doi = "10.2217/imt.09.12",
language = "English (US)",
volume = "1",
pages = "425--434",
journal = "Immunotherapy",
issn = "1750-743X",
publisher = "Future Medicine Ltd.",
number = "3",

}

TY - JOUR

T1 - Immunosuppressive therapy for autoimmune inner ear disease

AU - Buniel, Maria C.

AU - Geelan-Hansen, Katie

AU - Weber, Peter C.

AU - Tuohy, Vincent K.

PY - 2009/12/24

Y1 - 2009/12/24

N2 - Autoimmune inner ear disease (AIED) is a rare disease that is diagnosed after clinical suspicion and response to corticosteroids. AIED manifests as progressive, bilateral, although often asynchronous, sensorineural hearing loss and can be associated with vestibular symptoms. Since its description as a defined disease entity in 1979, the initial mainstay of treatment remains high-dose corticosteroids. Several animal models have been developed to assist in determining efficacy of immunosuppression in AIED, and several clinical studies have also investigated the role of both steroid and steroid-sparing treatments. Here we discuss the basic science and clinical research surrounding the history of immunosuppressive therapy in AIED.

AB - Autoimmune inner ear disease (AIED) is a rare disease that is diagnosed after clinical suspicion and response to corticosteroids. AIED manifests as progressive, bilateral, although often asynchronous, sensorineural hearing loss and can be associated with vestibular symptoms. Since its description as a defined disease entity in 1979, the initial mainstay of treatment remains high-dose corticosteroids. Several animal models have been developed to assist in determining efficacy of immunosuppression in AIED, and several clinical studies have also investigated the role of both steroid and steroid-sparing treatments. Here we discuss the basic science and clinical research surrounding the history of immunosuppressive therapy in AIED.

KW - Autoimmunity

KW - Corticosteroid

KW - Hearing loss

KW - Immunomodulation

KW - Immunosuppression

UR - http://www.scopus.com/inward/record.url?scp=77953458311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953458311&partnerID=8YFLogxK

U2 - 10.2217/imt.09.12

DO - 10.2217/imt.09.12

M3 - Review article

C2 - 19885385

AN - SCOPUS:77953458311

VL - 1

SP - 425

EP - 434

JO - Immunotherapy

JF - Immunotherapy

SN - 1750-743X

IS - 3

ER -